Doceree
Healthcare adtech platform for pharma, publishers and HCP targeting.
Available information varies by company and source.
Profile record updated:
Company facts
- Entity type
- COMPANY
- Founded
- 2020
- Headquarters
- 150 John F Kennedy Pkwy, Suite 403, Short Hills, NJ 07078
- Company size
- 201–500
- Market role
- AdTech Vendor
- Official website
- doceree.com
What Doceree does
Doceree operates a vertical adtech model for healthcare. It creates value by aggregating regulated healthcare media supply, clinical workflow access and HCP audience data, then packaging these capabilities into software and activation products for pharmaceutical advertisers, agencies and healthcare publishers. On the demand side, it enables campaign targeting, activation and measurement. On the supply side, it helps healthcare publishers monetise inventory. The business combines platform software, proprietary data assets and transaction-enabled media activation.
Category differentiation
Doceree is a healthcare-focused advertising technology company, not a general electronic health record vendor or a pharmaceutical manufacturer. It is distinct from broad horizontal adtech platforms because its products are built around HCP targeting, clinical workflows and regulated healthcare media.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Doceree is a private healthcare advertising technology company focused on connecting pharmaceutical marketers and agencies with healthcare professional audiences across clinical workflows, specialist medical publishers and related healthcare media environments. Its product suite includes programmatic buying tools, an ad server for healthcare publishers, HCP data and audience products, a marketplace for audience activation, and conversational and point-of-care messaging solutions tailored to regulated healthcare settings. The company generates revenue from media spend flowing through its healthcare advertising products, software access for publisher and advertiser tools, and data activation or usage fees tied to HCP audience intelligence. Its direct customers are pharmaceutical brands, healthcare marketers, agencies, programmatic buyers and healthcare publishers, rather than end consumers.
Company news briefing
Briefing updated:
Following leadership appointments including Kamya Elawadhi as President, Doceree has officially rolled out its Daily Command platform for pharma brand teams alongside generative AI connectors for ChatGPT and Claude. Furthermore, the company launched its Intent-Powered HCP Suite at Fierce Pharma Week 2026, focusing on real-time healthcare professional targeting through clinical intent signals, and expanded its Closed Loop Measurement framework across nine channels.
Business model & monetisation
Doceree monetises through a blended model of programmatic media spend, SaaS-style platform fees and data activation revenue. Pharmaceutical advertisers and agencies pay for targeted campaign delivery and audience activation, likely on CPM-based and media budget-linked pricing. Healthcare publishers can pay for or share economics around ad management and monetisation tooling. Data-oriented products such as HCP audience intelligence and marketplace access support usage-based, licensing or pay-as-you-go fees. Premium pricing is also supported by regulated point-of-care and clinical workflow integrations.
- Programmatic campaign spend from pharma advertisers and agencies
- Percentage take-rate on media activation
- Publisher monetisation and ad management platform access
- SaaS / software subscription
- HCP audience data and activation
- Usage-based data fees
- Audience marketplace transactions
- Pay-as-you-go marketplace pricing
- Conversational and premium point-of-care placements
- Premium media and platform fees
Products & capabilities
No products with linked sources are available in this view.
Programmatic stack & registry data
Registry entries and observed technical data do not establish certification, legal compliance or actual usage.
Doceree UK Limited
IAB vendor record: 1063
- Cookies declared
- Yes
- Non-cookie access declared
- Yes
- Declared purpose IDs
- 1, 2, 3, 4, 7
- Declared feature IDs
- 1, 2, 3
- Declared special purpose IDs
- 1, 2, 3
- Indexed sellers.json entries
- 62 · doceree.com
Products & market categories
Technology
Media Channel
Competitors & alternatives
- Internet Brands
Vertical SaaS, publishing and advertising platforms across specialist markets.
- DeepIntent
Healthcare-focused DSP and marketing cloud for pharmaceutical advertising.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Highlights of the Fierce Pharma Week 2026
Recorded impact score: 3.5/5
The night before Fierce Pharma Week 2026, Doceree launched its Intent-Powered HCP Suite with...
Daily Command Now Live – Doceree Launches AI System of Work for Pharma Brand Teams
Recorded impact score: 4/5
Now Live Daily Command is live Explore
Doceree Launches Generative AI Connectors for ChatGPT, Claude
Conversational AI / Generative AI in Healthcare MarTech · Recorded impact score: 3/5
Doceree announced the launch of its generative AI Connectors, native integrations that connect the company’s pharma-focused intelligence and governance to generative AI platforms starting with OpenAI (ChatGPT) and Anthropic (Claude). The Connectors bring Doceree’s Semmelweis clinical reasoning & orchestration model and its Daily Command commercial operating system into conversational AI environments while maintaining privacy-by-design: Semmelweis operates on de-identified HCP-level context and the system enforces human approval, auditability, and MLR/legal/regulatory guardrails. Doceree positions the launch as a way for pharma brands to safely engage audiences in generative-AI channels and to integrate those channels into the broader Doceree Marketplace and orchestration stack. The article was published via PR Newswire on July 15, 2026.
- Doceree launched generative AI Connectors that natively integrate with generative AI platforms, beginning with OpenAI’s ChatGPT and Anthropic’s Claude.
- The Connectors carry Doceree’s Semmelweis pharma-specific reasoning and orchestration model into generative AI environments.
Careers & open positions
Open positions indexed from verified career portals and applicant tracking systems.
| Position | Department | Location | Posted |
|---|---|---|---|
| Data Engineer(Mid-Level) | Software Development | India | |
| Software Developer(Mid-Level) | Software Development | India | |
| UI/UX Designer(Mid-Level) | Creative | India | |
| Business development(Mid-Level) | Sales & Business Development | India |
Explore company relationships
Questions about Doceree
What is Doceree?
Doceree is a healthcare advertising technology company that helps pharmaceutical marketers, agencies and healthcare publishers target and monetise healthcare professional audiences across clinical and digital environments.
Who uses Doceree?
Its users are mainly pharmaceutical brands, healthcare marketing teams, media agencies, programmatic buyers and healthcare publishers or media owners.
How does Doceree make money?
It makes money through programmatic media spend, platform and software fees, and data activation or usage fees tied to healthcare audience products and workflow integrations.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
15 publicly documented primary sources and citations linked across the market graph.
Continue your research on Doceree
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.